生命科学

Search documents
华测检测(300012):二季度归母净利润同比增长8.89%,加速推进海外战略并购
Guoxin Securities· 2025-08-26 10:55
2025 年收入同比增长 6.05%,归母净利润同比增长 7.03%。公司 2025 年上 半年实现收入 29.60 亿元,同比增长 6.05%,归母净利润 4.67 亿元,同 比增长 7.03%,扣非归母利润 4.39 亿元,同比增长 9.08%,其中二季度 收入 16.73 亿元,同比增长 4.62%,归母净利润 3.31 亿元,同比增长 8.89%,增长稳健。同期经营活动现金流净额约 1.75 亿元,去年同期 0.22 亿元,增长显著,业务质量显著改善。 证券研究报告 | 2025年08月26日 华测检测(300012.SZ) 优于大市 二季度归母净利润同比增长 8.89%,加速推进海外战略并购 消费品测试、贸易保障收入实现双位数增长,其他业务增速或逐步回升。2 025年上半年生命科学/工业测试/消费品测试/贸易保障/医药及医学服 务收入分别为12.73/6.01/5.22/4.26/1.37亿元,同比增速分别为1.11% /7.47%/13.15%/13.48%/1.30%,毛利率分别为51.16%/43.38%/41.47%/7 3.32%/19.40%,同比变动+1.74/-2.07/-1.76/ ...
广电计量(002967):24年全年业绩高增 25Q1订单双位数增长
Xin Lang Cai Jing· 2025-05-08 12:44
Core Viewpoint - The company reported a revenue of 3.207 billion yuan for 2024, representing a year-on-year growth of 11.01%, and a net profit attributable to shareholders of 352 million yuan, up 76.59% year-on-year [1] Financial Performance - For the entire year of 2024, the gross margin and net margin were 47.21% and 11.21%, respectively, showing an increase of 4.93 percentage points and 4.07 percentage points year-on-year [2] - In Q4 2024, the company achieved a revenue of 1.047 billion yuan, a year-on-year increase of 13.11% and a quarter-on-quarter increase of 28.32%, with a net profit of 163 million yuan, up 145.18% year-on-year and 49.75% quarter-on-quarter [2] - The gross margin and net margin for Q4 2024 were 52.73% and 16.7%, respectively, reflecting a year-on-year increase of 10.52 and 8.17 percentage points [2] - For Q1 2025, the company reported a revenue of 618 million yuan, a year-on-year increase of 5.16% but a quarter-on-quarter decrease of 40.98%, with a net profit of 5 million yuan, up 302.86% year-on-year but down 97.05% quarter-on-quarter [2] Business Segmentation - The company generated revenue from various segments in 2024: measurement (750 million yuan), reliability (780 million yuan), life sciences (500 million yuan), electromagnetic compatibility (360 million yuan), integrated circuits (260 million yuan), and EHS evaluation (180 million yuan), with year-on-year growth rates of +3.8%, +17.5%, +2.7%, +10.2%, +26.3%, and +2.6%, respectively [3] - The gross margins for these segments were 50.5%, 50.9%, 39.8%, 54.9%, 45.2%, and 38.0%, with year-on-year changes of +2.4, +7.4, +8.8, +4.0, +4.3, and -6.49 percentage points [3] - The company focuses on emerging industries, with over 80% of its business coming from sectors such as special industries, automotive, new energy, integrated circuits, commercial aerospace, communication, low-altitude economy, and artificial intelligence [3] Shareholder Returns - The company conducted active market value management, distributing a total dividend of 224 million yuan for the year, with a mid-year dividend of 140 million yuan and a total of 614 million yuan in dividends and share buybacks, representing 174% of the annual net profit attributable to shareholders [4] - The projected net profits for 2025 to 2027 are 420 million yuan, 510 million yuan, and 600 million yuan, reflecting year-on-year growth rates of +20%, +20%, and +18%, respectively [4]
广电计量(002967):24年全年业绩高增,25Q1订单双位数增长
Tianfeng Securities· 2025-05-08 09:48
Investment Rating - The report maintains a "Buy" rating for the company, with a target price not specified [5]. Core Insights - The company achieved a revenue of 3.207 billion yuan in 2024, representing a year-on-year growth of 11.01%, and a net profit attributable to the parent company of 352 million yuan, up 76.59% year-on-year [1]. - The gross margin and net margin for 2024 were 47.21% and 11.21%, respectively, showing improvements of 4.93 percentage points and 4.07 percentage points year-on-year [2]. - The company focuses on emerging industries, with over 80% of its business coming from sectors such as special industries, automotive, new energy, integrated circuits, commercial aerospace, communication, low-altitude economy, and artificial intelligence [3]. - The first quarter of 2025 saw a double-digit growth in overall order amounts, indicating a positive outlook for the company's performance in the upcoming quarters [3]. Financial Performance Summary - In Q4 2024, the company reported a revenue of 1.047 billion yuan, a year-on-year increase of 13.11%, and a net profit of 163 million yuan, up 145.18% year-on-year [2]. - The company’s revenue from various segments in 2024 was as follows: Measurement (750 million yuan, +3.8%), Reliability (780 million yuan, +17.5%), Life Sciences (500 million yuan, +2.7%), Electromagnetic Compatibility (360 million yuan, +10.2%), Integrated Circuits (260 million yuan, +26.3%), and EHS Evaluation (180 million yuan, +2.6%) [3]. - The company plans to distribute a total dividend of 224 million yuan for 2024, with a share buyback amounting to 390 million yuan, totaling 614 million yuan, which is 174% of the net profit attributable to the parent company [4]. Financial Forecast - The projected net profits for 2025, 2026, and 2027 are 422 million yuan, 508 million yuan, and 599 million yuan, respectively, reflecting year-on-year growth rates of 19.90%, 20.41%, and 17.80% [4]. - The company’s revenue is expected to grow to 3.757 billion yuan in 2025, with a growth rate of 17.16% [4].
国家发展改革委投资研究所研究员吴亚平:聚焦“投资于人” 加大“硬投资”力度
Shang Hai Zheng Quan Bao· 2025-04-15 18:11
Core Viewpoint - The inclusion of "investment in people" in the government work report signifies a significant shift in investment philosophy and financing policy direction in the process of advancing Chinese-style modernization [1] Group 1: Relationship Between "Investment in People" and "Investment in Material" - "Investment in people" requires substantial "hard investment," similar to "investment in material," as the ultimate goal of any investment activity is to serve human needs and development [2] - Investments aimed at meeting production needs generally fall under "investment in material," while those focused on promoting high-quality population development and meeting life needs, especially in terms of spiritual products and services, are categorized as "investment in people" [2] - Both "investment in people" and "investment in material" necessitate significant "hard investment" to enhance the supply capacity for human needs and development [2] Group 2: Focus Areas for "Investment in People" - "Investment in people" should strengthen demand-side management and policy support, increasing fiscal, financial, employment, and income distribution policies to enable more people to access spiritual products and services [3] - Key areas for "investment in people" include high-quality housing supply, reliable food and drug safety, improved living conditions, healthcare services, education and training, cultural and sports services, tourism, and emergency response systems [6] - Regions should focus on the needs of the people, aligning government investment directions with societal expectations, optimizing resource allocation, and enhancing both the quantity and quality of "hard investment" [6] Group 3: Impact on "Investment in Material" - "Investment in people" and "investment in material" should be coordinated in resource allocation, as both types of capital are complementary and mutually reinforcing [4] - It is essential not to view "investment in material" as ineffective or low-level, nor to assume that "investment in people" projects are inherently beneficial; all investments with real or potential demand contribute to economic and social development [4] - The current investment strategy should shift from primarily new construction to a balance of renovation and new investment, focusing on modern industrial systems and addressing key areas and weaknesses [5]